Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELIDACE: TNF-alpha Inhibitors in Moderate to Severe Psoriasis
NCT01237262Phase 4Unknown
- Sponsor
- Università di Padova
- Start
- Nov 2010
- Primary completion
- Nov 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of adalimumab in psoriasis, sponsored by Università di Padova. Status: unknown.
02
Drugs
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT01237262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01237262.